US securities house Morgan Stanley has slashed its 12-month target price for the bank, which includes NatWest, by 13% to 650p. It has also downgraded its recommendation from overweight to equal weight. Rival broker Prudential-Bache has downgraded from buy to hold. Both have taken into account the strong performance of the shares, up from a low of 1195p during the past year, as the benefits of integration from the NatWest deal percolate through. But it looks as if most of the merger benefits have now been achieved.